1
/
of
1
GalNAcβ (1-3) GlcNAc-β-pNP [CAS 1456553-26-6]
GalNAcβ (1-3) GlcNAc-β-pNP [CAS 1456553-26-6]
SKU:QM-0166359
Price on request
Quantity
Request quote or documents
![GalNAcβ (1-3) GlcNAc-β-pNP [CAS 1456553-26-6]](http://quantimol.com/cdn/shop/files/quantimol-021.png?v=1773515276&width=1445)
Product Details
-
Description
GalNAcβ (1-3) GlcNAc-β-pNP is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
-
CAS Number
[1456553-26-6]
-
Molecular Formula
C22H31N3O13
-
Molecular Weight
545.49
-
Smiles
CC(N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC2=CC=C(C=C2)[N+]([O-])=O)CO)O)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)NC(C)=O)=O
-
Target
Biochemical Assay Reagents
-
Solubility
10 mM in DMSO
-
Shipping Conditions
Room temperature
-
Hazard Statement
H302-H315-H319-H335
-
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
Related Products
- QM-0046499 Xpnpep3 Rat Pre-designed siRNA Set A
- QM-0043980 Xpnpep1 Rat Pre-designed siRNA Set A
- QM-0042997 Xpnpep2 Rat Pre-designed siRNA Set A
- QM-0039984 Xpnpep3 Mouse Pre-designed siRNA Set A
- QM-0037490 Xpnpep1 Mouse Pre-designed siRNA Set A
- QM-0036518 Xpnpep2 Mouse Pre-designed siRNA Set A
- QM-0025936-01 Z-Val-Lys-Met-AMC (TFA)
- QM-0025934 Z-VEID-AFC (TFA)
- QM-0025807 Z-LRGG-AMC (TFA)
- QM-0020831 X-GAL (solution) [CAS 7240-90-6]
Other industry favorites
- QM-0046499 Xpnpep3 Rat Pre-designed siRNA Set A
- QM-0043980 Xpnpep1 Rat Pre-designed siRNA Set A
- QM-0158040-01 Triamcinolone [CAS 124-94-7]
- QM-0152746-01 X-GAL [CAS 7240-90-6]
- QM-0160938-01 β-Ala-Lys (AMCA) [CAS 180342-52-3]
- QM-0172351-01 Z-Gly-Gly-Arg-AMC [CAS 66216-78-2]
- QM-0079583-01 UAMC-1110 [CAS 1448440-52-5]
- QM-0205960-01 Triamcinolone hexacetonide [CAS 5611-51-8]
- QM-0184815-01 Z-DEVD-AMC
- QM-0147714-01 Z-Leu-Arg-AMC [CAS 156192-32-4]
GalNAcβ (1-3) GlcNAc-β-pNP [CAS 1456553-26-6]
GalNAcβ (1-3) GlcNAc-β-pNP is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.